0001654954-23-009601.txt : 20230724
0001654954-23-009601.hdr.sgml : 20230724
20230724164608
ACCESSION NUMBER: 0001654954-23-009601
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230720
FILED AS OF DATE: 20230724
DATE AS OF CHANGE: 20230724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brooks Michael J
CENTRAL INDEX KEY: 0001779126
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 231105539
MAIL ADDRESS:
STREET 1: C/O EDESA BIOTECH INC.
STREET 2: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
BUSINESS PHONE: (905) 475-1234
MAIL ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
4/A
1
section16.xml
FORM 4A
X0508
4/A
2023-07-20
2023-07-21
0001540159
Edesa Biotech, Inc.
EDSA
0001779126
Brooks Michael J
C/O EDESA BIOTECH INC.
100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
false
true
false
false
President
false
Share Option (right to buy)
0.8277
2023-07-20
4
A
false
80000
0
A
2033-07-20
Common Shares
80000
80000
D
This option vests monthly in equal proportions over 36 months beginning on the date of grant.
This amendment on Form 4/A is being filed to amend the Form 4 filed on July 21, 2023, solely to correct an administrative error in the expiration date of the Share Option previously reported in Column 6 of Table II.
/s/ Michael J. Brooks
2023-07-24